Revolution Medicines, Inc. - RVMD
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 27, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Baker Bros. Advisors LP | 4.9% | 9,455,357 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Baker Bros. Advisors (GP) LLC | 4.9% | 9,455,357 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Julian C. Baker | 4.9% | 9,455,357 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Felix J. Baker | 4.9% | 9,455,357 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Management Group LLP | 3.6% | 6,987,639 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Group Holdings LLP | 3.6% | 6,987,639 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Investment Advisors Holdings LLP | 3.6% | 6,987,639 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Farallon Capital Partners, L.P. | 0.5% | 1,057,562 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Farallon Capital Institutional Partners, L.P. | 0.7% | 1,377,579 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Farallon Capital Institutional Partners II, L.P. | 0.2% | 332,755 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Farallon Capital Institutional Partners III, L.P. | 0.1% | 164,197 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Four Crossings Institutional Partners V, L.P. | 0.1% | 238,987 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Farallon Capital Offshore Investors II, L.P. | 1.3% | 2,482,796 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Farallon Capital (AM) Investors, L.P. | 0.1% | 151,742 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Farallon Capital F5 Master I, L.P. | 0.2% | 370,466 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Farallon Healthcare Partners Master, L.P. | 4.4% | 8,420,065 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Farallon Partners, L.L.C. | 7.4% | 14,225,683 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Farallon Institutional (GP) V, L.L.C. | 0.1% | 238,987 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Farallon F5 (GP), L.L.C. | 0.2% | 370,466 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Farallon Healthcare Partners (GP), L.L.C. | 4.4% | 8,420,065 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Dapice Joshua J. | 7.5% | 14,596,149 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Dreyfuss, Philip D. | 7.5% | 14,596,149 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Dunn Hannah E. | 7.5% | 14,596,149 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Fried, Richard B | 0.0% | 0 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Gehani, Varun N. | 7.5% | 14,596,149 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Giauque, Nicolas | 7.5% | 14,596,149 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Husen, Avner A. | 7.5% | 14,596,149 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Kim, David T. | 7.5% | 14,596,149 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Linn, Michael G. | 7.5% | 14,596,149 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Luo Patrick (Cheng) | 7.5% | 14,596,149 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Patel, Rajiv A. | 0.0% | 0 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Roberts, Jr., Thomas G. | 7.5% | 14,596,149 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Saito Edric C. | 7.5% | 14,596,149 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Seybold, William | 0.0% | 0 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Short Daniel S. | 7.5% | 14,596,149 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Spokes, Andrew J. M. | 7.5% | 14,596,149 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Warren, John R. | 7.5% | 14,596,149 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Wehrly, Mark C. | 7.5% | 14,596,149 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 6.1% | 11,356,054 | View |
| Nov 05, 2025 | SCHEDULE 13G | FMR LLC | 5.0% | 9,401,687 | View |
| Nov 05, 2025 | SCHEDULE 13G | Abigail P. Johnson | 5.0% | 9,401,687 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.